Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia (Q37810067)

23 August 2017

Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia (English)

1 reference

23 August 2017

1 reference

1

Helen A Papadaki

1 reference

23 August 2017

Charalampos Pontikoglou

series ordinal

2

1 reference

PubMed ID

21082926

23 August 2017

language of work or name

1 reference

1 December 2008

1 reference

Expert Review of Hematology

23 August 2017

1 reference

23 August 2017

1

1 reference

23 August 2017

2

1 reference

23 August 2017

217-229

1 reference

Neutrophil disorders and their management

23 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

How many neutrophils are enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Acute and chronic neutropenias. What is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Primary and secondary autoimmune neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Clinical features of large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

T-cell large granular leukemia and related proliferations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Human neutrophil alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Granulocyte antigens and antibody detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Report on the Fourth International Granulocyte Immunology Workshop: progress toward quality assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The Detection of Granulocyte Alloantibodies with an Indirect Immunofluorescence Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Congenital and acquired neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Report on the second international granulocyte serology workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Light chain composition of serum granulocyte binding immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Autoimmune neutropenia: clinical and laboratory studies in 143 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Severe autoimmune neutropenia associated with bone marrow sea-blue histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Autoimmune granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Neutrophil elastase in cyclic and severe congenital neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Severe congenital neutropenia: inheritance and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Autoimmune neutropenia of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Guidelines on the use of intravenous immune globulin for hematologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Monoclonal antibodies in the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Rituximab for the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The effect of treatment with Campath-1H in patients with autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

CAMPATH-1H in the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Non-immune chronic idiopathic neutropenia of adult: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Chronic idiopathic neutropenias and severe congenital neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Increased frequency of HLA-DRB1*1302 haplotype in patients with nonimmune chronic idiopathic neutropenia of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Soluble Fc gamma receptor III in human plasma originates from release by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Two patients with nonimmune chronic idiopathic neutropenia of adults developing acute myeloid leukemia with aberrant phenotype and complex karyotype but no mutations in granulocyte colony-stimulating factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

The relationship of aplastic anemia and PNH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474086.1.2.217

21 January 2018

Identifiers

DOI

10.1586/17474086.1.2.217

1 reference

23 August 2017

1 reference

PubMed ID

21082926